Biomerica/$BMRA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biomerica
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
Ticker
$BMRA
Sector
Primary listing
Employees
54
Headquarters
Website
Biomerica Metrics
BasicAdvanced
$6.1m
-
-$1.55
0.29
-
Price and volume
Market cap
$6.1m
Beta
0.29
52-week high
$4.60
52-week low
$1.87
Average daily volume
21k
Financial strength
Current ratio
2.641
Quick ratio
1.459
Total debt to equity
5.819
Profitability
EBITDA (TTM)
-5.268
Gross margin (TTM)
4.37%
Net profit margin (TTM)
-96.46%
Operating margin (TTM)
-123.67%
Effective tax rate (TTM)
-0.53%
Revenue per employee (TTM)
$80,000
Management effectiveness
Return on assets (TTM)
-54.58%
Return on equity (TTM)
-94.32%
Valuation
Price to revenue (TTM)
1.225
Price to book
1.8
Price to tangible book (TTM)
1.93
Price to free cash flow (TTM)
-1.662
Free cash flow yield (TTM)
-60.16%
Free cash flow per share (TTM)
-1.185
Growth
Revenue change (TTM)
-23.79%
Earnings per share change (TTM)
-27.38%
3-year revenue growth (CAGR)
-23.15%
10-year revenue growth (CAGR)
-2.02%
3-year earnings per share growth (CAGR)
-28.87%
10-year earnings per share growth (CAGR)
47.09%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs